Aerosol Production During Blood and Urine Pre-analytical Processing and Handling in a Hospital Biochemistry Clinical Laboratory During the COVID-19 Pandemic.
Front Public Health
; 9: 643724, 2021.
Article
in English
| MEDLINE | ID: covidwho-1221992
ABSTRACT
The SARS-CoV-2 pandemic has created a troublesome issue for employees in biochemistry clinical laboratories due to fears of aerosol generation during sample treatment. This study was designed to assess aerosol production during the pre-analytical procedures for blood and urine samples using a model bacterium. Air sampling and surface swabbing were conducted during four typical procedures. Bacteria were not recovered in any air or surface samples. Other studies have reported low and undetectable SARS-CoV-2 RNA in blood and urine samples, respectively. Therefore, the occupational risk for employees appears to be low in terms of aerosol exposure from processing SARS-CoV-2 patient samples.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pandemics
/
COVID-19
Type of study:
Prognostic study
Limits:
Humans
Language:
English
Journal:
Front Public Health
Year:
2021
Document Type:
Article
Affiliation country:
Fpubh.2021.643724
Similar
MEDLINE
...
LILACS
LIS